Head and neck cancer survivorship consensus statement from the American Head and Neck Society
Objectives To provide a consensus statement describing best practices and evidence
regarding head and neck cancer survivorship. Methods Key topics regarding head and neck …
regarding head and neck cancer survivorship. Methods Key topics regarding head and neck …
Contemporary Imaging and Reporting Strategies for Head and Neck Cancer: MRI, FDG PET/MRI, NI-RADS, and Carcinoma of Unknown Primary—AJR Expert Panel …
S Mukherjee, NJ Fischbein… - American Journal of …, 2023 - Am Roentgen Ray Soc
CT, MRI, and FDG PET/CT play major roles in the diagnosis, staging, treatment planning,
and surveillance of head and neck cancers. Nonetheless, an evolving understanding of …
and surveillance of head and neck cancers. Nonetheless, an evolving understanding of …
Costs associated with imaging surveillance after treatment for head and neck cancer
CC Nocon, A Kennedy, J Jaffe, J Pruitt… - … –Head & Neck …, 2021 - jamanetwork.com
Importance The National Comprehensive Cancer Network recommends imaging within 6
months after treatment for head and neck cancer (HNC). Further imaging is recommended …
months after treatment for head and neck cancer (HNC). Further imaging is recommended …
Posttreatment Surveillance Imaging After Radiation for Head and Neck Cancer
Importance The role of surveillance imaging after treatment for head and neck cancer is
controversial and evidence to support decision-making is limited. Objective To determine the …
controversial and evidence to support decision-making is limited. Objective To determine the …
Evaluation of optimal assessment schedules for surveillance after definitive locoregional treatment of locally advanced head and neck cancer: a retrospective cohort …
HI Lee, J Lee, JH Lee, HG Wu, JH Kim… - … –Head & Neck …, 2022 - jamanetwork.com
Importance In clinical practice, assessment schedules are often arbitrarily determined after
definitive treatment of head and neck cancer (HNC), producing heterogeneous and …
definitive treatment of head and neck cancer (HNC), producing heterogeneous and …
Oral Cavity Cancer Surgical and Nodal Management: A Review From the American Head and Neck Society
A Eskander, PT Dziegielewski, MR Patel… - … –Head & Neck …, 2024 - jamanetwork.com
Importance Lymph node metastases from oral cavity cancers are seen frequently, and there
is still inconsistency, and occasional controversies, regarding the surgical management of …
is still inconsistency, and occasional controversies, regarding the surgical management of …
The economic impact of circulating tumor-tissue modified HPV DNA for the post-treatment surveillance of HPV-driven oropharyngeal cancer: a simulation
Purpose Following treatment of HPV-driven oropharynx cancer, surveillance
nasopharyngoscopy and imaging are often performed but are expensive and frequently …
nasopharyngoscopy and imaging are often performed but are expensive and frequently …
PET/MR imaging in head and neck cancer
M Becker, C de Vito, N Dulguerov… - Magnetic Resonance …, 2023 - mri.theclinics.com
The rationale behind the integration of PET and MR imaging lies in the complementary
strengths of each modality. PET provides metabolic information using radiotracers, whereas …
strengths of each modality. PET provides metabolic information using radiotracers, whereas …
Post-treatment surveillance imaging in head and neck cancer: a systematic review
S Van Hoe, R Hermans - Insights into Imaging, 2024 - Springer
Background In patients treated for head and neck cancer, imaging studies are usually
obtained within 3–6 months after treatment for assessment of treatment response. After 6 …
obtained within 3–6 months after treatment for assessment of treatment response. After 6 …
Locoregional and distant recurrence for HPV-associated oropharyngeal cancer using AJCC 8 staging
KJ Contrera, TD Smile, C Mahomva, W Wei… - Oral Oncology, 2020 - Elsevier
Introduction The objective of this study is to evaluate locoregional and distant failure for
human papillomavirus-associated (HPV+) oropharyngeal squamous cell carcinoma …
human papillomavirus-associated (HPV+) oropharyngeal squamous cell carcinoma …